注意欠陥・多動性障害 (Japanese Wikipedia)

“ICD-11（2023年1月版）の代表語の和訳案の確定について ICD-11の分類の表記に用いる用語の和訳案について（2024年7月24日ICD専門委員会資料等より）”. 2024年9月19日閲覧。
平成19年10月26日付厚生労働省医薬食品局総務課長、審査管理課長、安全対策課長、監視指導・麻薬対策課長通知薬食総発第1026001号、薬食審査発第1026002号、薬食安発第1026001号、薬食監麻発第1026003号通知 PDF

e-healthnet.mhlw.go.jp

“ASD（自閉スペクトラム症、アスペルガー症候群）について”. e-ヘルスネット. 厚生労働省 (2020年5月28日). 2022年7月22日閲覧。

mixonline.jp

薬食審・第一部会　塩野義の小児AD／HD治療薬など９製品審議、承認了承ミクスOnline 2019年2月22日

msu.edu

news.msu.edu

“Nearly 1 million children potentially misdiagnosed with ADHD”. Michigan State University (2020年8月17日). 2010年8月20日時点のオリジナルよりアーカイブ。2022年12月6日閲覧。

nbcsports.com

“Chris Davis opens up about his Adderall suspension: "It was a moment of weakness"”. NBC Sports (2015年1月31日). 2025年5月13日閲覧。

nhk.or.jp

www3.nhk.or.jp

日本放送協会. “注意欠陥・多動性障害の子脳に共通の特徴発見福井大学 | NHKニュース” (日本語). NHKニュース. オリジナルの2018年12月3日時点におけるアーカイブ。 2018年12月4日閲覧。

nice.org.uk

原文：For adults with ADHD, drug treatment should be the first-line treatment unless the person would prefer a psychological approach. (英国国立医療技術評価機構 2008, Chapt.1.7.1) CG72 - Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults (Report). 英国国立医療技術評価機構. 2008年7月.
英国国立医療技術評価機構 2008, Information for the public. CG72 - Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults (Report). 英国国立医療技術評価機構. 2008年7月.
英国国立医療技術評価機構 2008, Chapt.1.5.1.1. CG72 - Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults (Report). 英国国立医療技術評価機構. 2008年7月.
英国国立医療技術評価機構 2008, Chapt.1.5.2.1. CG72 - Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults (Report). 英国国立医療技術評価機構. 2008年7月.
英国国立医療技術評価機構 2008, Chapt.1.5.2. CG72 - Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults (Report). 英国国立医療技術評価機構. 2008年7月.
英国国立医療技術評価機構 2008, Chapt.1.7.1. CG72 - Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults (Report). 英国国立医療技術評価機構. 2008年7月.
英国国立医療技術評価機構 2008, Introduction. CG72 - Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults (Report). 英国国立医療技術評価機構. 2008年7月.

nih.gov

pubmed.ncbi.nlm.nih.gov

Caye, Arthur; Rocha, Thiago Botter-Maio; Anselmi, Luciana; et al. (2016). “Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood”. JAMA Psychiatry 73 (7): 705. doi:10.1001/jamapsychiatry.2016.0383. ISSN 2168-622X. PMID 27192050.
Marshall, Paul; Schroeder, Ryan; O’Brien, Jeffrey; et al. (2010). “Effectiveness of symptom validity measures in identifying cognitive and behavioral symptom exaggeration in adult attention deficit hyperactivity disorder”. The Clinical Neuropsychologist 24 (7): 1204-1237. doi:10.1080/13854046.2010.514290. PMID 20845231.
Barbaresi, W. J.; Colligan, R. C.; Weaver, A. L.; et al. (2013). “Mortality, ADHD, and Psychosocial Adversity in Adults With Childhood ADHD: A Prospective Study”. PEDIATRICS 131 (4): 637-644. doi:10.1542/peds.2012-2354. PMC 3821174. PMID 23460687.
Willoughby, Michael T. (2003-1). “Developmental course of ADHD symptomatology during the transition from childhood to adolescence: a review with recommendations”. Journal of Child Psychology and Psychiatry, and Allied Disciplines 44 (1): 88-106. ISSN 0021-9630. PMID 12553414.
Neale, BM; Medland, SE; Ripke, S et al. (September 2010). “Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder”. J Am Acad Child Adolesc Psychiatry 49 (9): 884-897. doi:10.1016/j.jaac.2010.06.008. PMC 2928252. PMID 20732625.
Kim, Jae Han; Kim, Jong Yeob; Lee, Jinhee; Jeong, Gwang Hun; Lee, Eun; Lee, San; Lee, Keum Hwa; Kronbichler, Andreas et al. (2020-11-01). “Environmental risk factors, protective factors, and peripheral biomarkers for ADHD: an umbrella review” (English). The Lancet Psychiatry 7 (11): 955–970. doi:10.1016/S2215-0366(20)30312-6. ISSN 2215-0366. PMID 33069318.
te Meerman, Sanne; Batstra, Laura; Grietens, Hans; et al. (2017). “ADHD: a critical update for educational professionals”. International Journal of Qualitative Studies on Health and Well-being 12 (sup1): 1298267. doi:10.1080/17482631.2017.1298267. PMC 5510202. PMID 28532329.
Lars Lien et al. "Consumption of Soft Drinks and Hyperactivity, Mental Distress, and Conduct Problems Among Adolescents in Oslo, Norway" American Journal of Public Health Vol96, No.10 2006, pp1815-1820. PMID 17008578
Bouchard MF, Bellinger DC, Wright RO, Weisskopf MG. (2010-6). “Attention-deficit/hyperactivity disorder and urinary metabolites of organophosphate pesticides.”. en:Pediatrics. 125 (6): e1270-7. doi:10.1542/peds.2009-3058. PMC 3706632. PMID 20478945.
Walitza, S; Drechsler, R; Ball, J (August 2012). “Das schulkind mit ADHS [The school child with ADHD]” (ドイツ語). Ther Umsch 69 (8): 467-73. doi:10.1024/0040-5930/a000316. PMID 22851461.
McBurnett, K; Pfiffner, LJ (November 2009). “Treatment of aggressive ADHD in children and adolescents: Conceptualization and treatment of comorbid behavior disorders”. Postgrad Med 121 (6): 158-165. doi:10.3810/pgm.2009.11.2084. PMID 19940426.
Carroll, Bernard J (2018). “Carmen Keith Conners”. Neuropsychopharmacology 43 (2): 455-455. doi:10.1038/npp.2017.240. PMID 29230032. https://doi.org/10.1038/npp.2017.240.
Jensen PS, Arnold LE, Swanson JM, et al. (August 2007). “3-year follow-up of the NIMH MTA study”. J Am Acad Child Adolesc Psychiatry 46 (8): 989-1002. doi:10.1097/CHI.0b013e3180686d48. PMID 17667478.
Molina BS, Hinshaw SP, Swanson JM, et al. (May 2009). “The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study”. J Am Acad Child Adolesc Psychiatry 48 (5): 484-500. doi:10.1097/CHI.0b013e31819c23d0. PMC 3063150. PMID 19318991.
Swanson, James M.; Arnold, L. Eugene; Molina, Brooke S.G.; et al. (2017). “Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression”. Journal of Child Psychology and Psychiatry 58 (6): 663-678. doi:10.1111/jcpp.12684. PMID 28295312.
Riddle, Mark A.; Yershova, Kseniya; Lazzaretto, Deborah; et al. (2013). “The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-Year Follow-Up”. Journal of the American Academy of Child & Adolescent Psychiatry 52 (3): 264-278.e2. doi:10.1016/j.jaac.2012.12.007. PMC 3660093. PMID 23452683.
Storebø, Ole Jakob; Ramstad, Erica; Krogh, Helle B.; et al. (2015). “Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)”. Cochrane Database of Systematic Reviews (11): CD009885. doi:10.1002/14651858.CD009885.pub2. PMID 26599576.
Boesen, Kim; Saiz, Luis Carlos; Erviti, Juan; et al. (2017). “The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder”. Evidence Based Medicine 22 (4): 143-147. doi:10.1136/ebmed-2017-110716. PMC 5537554. PMID 28705922.
MacKenzie, Lynn E.; Abidi, Sabina; Fisher, Helen L.; et al. (2016). “Stimulant Medication and Psychotic Symptoms in Offspring of Parents With Mental Illness”. Pediatrics 137 (1): e20152486. doi:10.1542/peds.2015-2486. PMID 26719291.
Howard, Jeffrey T.; Walick, Kristina S.; Rivera, Jessica C.; et al. (2017). “Preliminary Evidence of an Association Between ADHD Medications and Diminished Bone Health in Children and Adolescents”. Journal of Pediatric Orthopaedics 37 (5): 348-354. doi:10.1097/BPO.0000000000000651. PMID 26398435.
Uddin, Sardar M. Z.; Robison, Lisa S.; Fricke, Dennis; et al. (2018). “Methylphenidate regulation of osteoclasts in a dose- and sex-dependent manner adversely affects skeletal mechanical integrity”. Scientific Reports 8 (1): 1515. doi:10.1038/s41598-018-19894-x. PMC 5784171. PMID 29367750.
Danborg, Pia Brandt; Simonsen, Anders Lykkemark; Gøtzsche, Peter C.; et al. (2017). “Impaired reproduction after exposure to ADHD drugs: Systematic review of animal studies”. International Journal of Risk & Safety in Medicine 29 (1-2): 107-124. doi:10.3233/JRS-170743. PMC 5611805. PMID 28885224. https://doi.org/10.3233/JRS-170743.
Cliff-Eribo KO, Sammons H, Choonara I. (2016-10). “Systematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases.”. en:Expert Opinion on Drug Safety. 15 (10): 1321-8. doi:10.1080/14740338.2016.1221921. PMID 27501085.
Castellanos FX, Tannock R (2002). “Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes”. Nat. Rev. Neurosci. 3 (8): 617-28. doi:10.1038/nrn896. PMID 12154363.
Martinussen R, Hayden J, Hogg-Johnson S, Tannock R (2005). “A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder”. J Am Acad Child Adolesc Psychiatry 44 (4): 377-84. doi:10.1097/01.chi.0000153228.72591.73. PMID 15782085.
Klingberg T, Forssberg H, Westerberg H (2002). “Training of working memory in children with ADHD”. J Clin Exp Neuropsychol 24 (6): 781-91. doi:10.1076/jcen.24.6.781.8395. PMID 12424652.
Klingberg T, Fernell E, Olesen PJ, Johnson M, Gustafsson P, Dahlström K, Gillberg CG, Forssberg H, Westerberg H (2005). “Computerized training of working memory in children with ADHD--a randomized, controlled trial”. J Am Acad Child Adolesc Psychiatry 44 (2): 177-86. doi:10.1097/00004583-200502000-00010. PMID 15689731.
Rucklidge, Julia J.; Eggleston, Matthew J.F.; Johnstone, Jeanette M.; et al. (2018). “Vitamin-mineral treatment improves aggression and emotional regulation in children with ADHD: a fully blinded, randomized, placebo-controlled trial”. Journal of Child Psychology and Psychiatry 59 (3): 232-246. doi:10.1111/jcpp.12817. PMID 28967099.
Galéra, C.; Melchior, M.; Chastang, J.-F.; Bouvard, M.-P.; Fombonne, E. (2009-11). “Childhood and adolescent hyperactivity-inattention symptoms and academic achievement 8 years later: the GAZEL Youth study” (英語). Psychological Medicine 39 (11): 1895-1906. doi:10.1017/S0033291709005510. ISSN 0033-2917. PMC 2797029. PMID 19335935.
Rösler, Michael; Retz, Wolfgang; Retz-Junginger, Petra; Hengesch, Georges; Schneider, Marc; Supprian, Tilman; Schwitzgebel, Petra; Pinhard, Katrin et al. (2004-12). “Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates”. European Archives of Psychiatry and Clinical Neuroscience 254 (6): 365-371. doi:10.1007/s00406-004-0516-z. ISSN 0940-1334. PMID 15538605.
Barkley, RA; Peters, H (November 2012). “The earliest reference to ADHD in the medical literature? Melchior Adam Weikard's description in 1775 of attention deficit (Mangel der Aufmerksamkeit, Attentio Volubilis)”. J Atten Disord 16 (8): 623-30. doi:10.1177/1087054711432309. PMID 22323122.
Lange KW, Reichl S, Lange KM, Tucha L, Tucha O (2010). “The history of attention deficit hyperactivity disorder”. Atten Defic Hyperact Disord 2 (4): 241-55. doi:10.1007/s12402-010-0045-8. PMC 3000907. PMID 21258430.
Strohl MP (2011). “Bradley's Benzedrine studies on children with behavioral disorders”. Yale J Biol Med 84 (1): 27-33. PMC 3064242. PMID 21451781.

pmc.ncbi.nlm.nih.gov

Barbaresi, W. J.; Colligan, R. C.; Weaver, A. L.; et al. (2013). “Mortality, ADHD, and Psychosocial Adversity in Adults With Childhood ADHD: A Prospective Study”. PEDIATRICS 131 (4): 637-644. doi:10.1542/peds.2012-2354. PMC 3821174. PMID 23460687.
Neale, BM; Medland, SE; Ripke, S et al. (September 2010). “Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder”. J Am Acad Child Adolesc Psychiatry 49 (9): 884-897. doi:10.1016/j.jaac.2010.06.008. PMC 2928252. PMID 20732625.
te Meerman, Sanne; Batstra, Laura; Grietens, Hans; et al. (2017). “ADHD: a critical update for educational professionals”. International Journal of Qualitative Studies on Health and Well-being 12 (sup1): 1298267. doi:10.1080/17482631.2017.1298267. PMC 5510202. PMID 28532329.
Bouchard MF, Bellinger DC, Wright RO, Weisskopf MG. (2010-6). “Attention-deficit/hyperactivity disorder and urinary metabolites of organophosphate pesticides.”. en:Pediatrics. 125 (6): e1270-7. doi:10.1542/peds.2009-3058. PMC 3706632. PMID 20478945.
Molina BS, Hinshaw SP, Swanson JM, et al. (May 2009). “The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study”. J Am Acad Child Adolesc Psychiatry 48 (5): 484-500. doi:10.1097/CHI.0b013e31819c23d0. PMC 3063150. PMID 19318991.
Riddle, Mark A.; Yershova, Kseniya; Lazzaretto, Deborah; et al. (2013). “The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-Year Follow-Up”. Journal of the American Academy of Child & Adolescent Psychiatry 52 (3): 264-278.e2. doi:10.1016/j.jaac.2012.12.007. PMC 3660093. PMID 23452683.
Boesen, Kim; Saiz, Luis Carlos; Erviti, Juan; et al. (2017). “The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder”. Evidence Based Medicine 22 (4): 143-147. doi:10.1136/ebmed-2017-110716. PMC 5537554. PMID 28705922.
Uddin, Sardar M. Z.; Robison, Lisa S.; Fricke, Dennis; et al. (2018). “Methylphenidate regulation of osteoclasts in a dose- and sex-dependent manner adversely affects skeletal mechanical integrity”. Scientific Reports 8 (1): 1515. doi:10.1038/s41598-018-19894-x. PMC 5784171. PMID 29367750.
Danborg, Pia Brandt; Simonsen, Anders Lykkemark; Gøtzsche, Peter C.; et al. (2017). “Impaired reproduction after exposure to ADHD drugs: Systematic review of animal studies”. International Journal of Risk & Safety in Medicine 29 (1-2): 107-124. doi:10.3233/JRS-170743. PMC 5611805. PMID 28885224. https://doi.org/10.3233/JRS-170743.
Galéra, C.; Melchior, M.; Chastang, J.-F.; Bouvard, M.-P.; Fombonne, E. (2009-11). “Childhood and adolescent hyperactivity-inattention symptoms and academic achievement 8 years later: the GAZEL Youth study” (英語). Psychological Medicine 39 (11): 1895-1906. doi:10.1017/S0033291709005510. ISSN 0033-2917. PMC 2797029. PMID 19335935.
Lange KW, Reichl S, Lange KM, Tucha L, Tucha O (2010). “The history of attention deficit hyperactivity disorder”. Atten Defic Hyperact Disord 2 (4): 241-55. doi:10.1007/s12402-010-0045-8. PMC 3000907. PMID 21258430.
Strohl MP (2011). “Bradley's Benzedrine studies on children with behavioral disorders”. Yale J Biol Med 84 (1): 27-33. PMC 3064242. PMID 21451781.

ncbi.nlm.nih.gov

Willoughby, Michael T. (2003-1). “Developmental course of ADHD symptomatology during the transition from childhood to adolescence: a review with recommendations”. Journal of Child Psychology and Psychiatry, and Allied Disciplines 44 (1): 88-106. ISSN 0021-9630. PMID 12553414.
National Collaborating Centre for Mental Health (2009). Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults. NICE Clinical Guidelines. 72. Leicester: British Psychological Society. ISBN 978-1-85433-471-8. オリジナルの13 January 2016時点におけるアーカイブ。
Neale, BM; Medland, SE; Ripke, S et al. (September 2010). “Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder”. J Am Acad Child Adolesc Psychiatry 49 (9): 884-897. doi:10.1016/j.jaac.2010.06.008. PMC 2928252. PMID 20732625.
Molina BS, Hinshaw SP, Swanson JM, et al. (May 2009). “The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study”. J Am Acad Child Adolesc Psychiatry 48 (5): 484-500. doi:10.1097/CHI.0b013e31819c23d0. PMC 3063150. PMID 19318991.
Riddle, Mark A.; Yershova, Kseniya; Lazzaretto, Deborah; et al. (2013). “The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-Year Follow-Up”. Journal of the American Academy of Child & Adolescent Psychiatry 52 (3): 264-278.e2. doi:10.1016/j.jaac.2012.12.007. PMC 3660093. PMID 23452683.
Efficacy and safety of acupuncture in children: an overview of systematic reviews.
Rösler, Michael; Retz, Wolfgang; Retz-Junginger, Petra; Hengesch, Georges; Schneider, Marc; Supprian, Tilman; Schwitzgebel, Petra; Pinhard, Katrin et al. (2004-12). “Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates”. European Archives of Psychiatry and Clinical Neuroscience 254 (6): 365-371. doi:10.1007/s00406-004-0516-z. ISSN 0940-1334. PMID 15538605.
Lange KW, Reichl S, Lange KM, Tucha L, Tucha O (2010). “The history of attention deficit hyperactivity disorder”. Atten Defic Hyperact Disord 2 (4): 241-55. doi:10.1007/s12402-010-0045-8. PMC 3000907. PMID 21258430.
Strohl MP (2011). “Bradley's Benzedrine studies on children with behavioral disorders”. Yale J Biol Med 84 (1): 27-33. PMC 3064242. PMID 21451781.

nimh.nih.gov

National Institute of Mental Health (2008年). “Attention Deficit Hyperactivity Disorder (ADHD)”. アメリカ国立衛生研究所. 2015年11月1日閲覧。
“Attention Deficit Hyperactivity Disorder (ADHD)”. The National Institute of Mental Health (NIMH). 2013年11月15日閲覧。
“Short-term Intensive Treatment Not Likely to Improve Long-term Outcomes for Children with ADHD”. アメリカ国立精神衛生研究所 (2009年3月26日). 2018年3月10日閲覧。
“The Multimodal Treatment of Attention Deficit Hyperactivity Disorder Study (MTA):Questions and Answers”. アメリカ国立精神衛生研究所 (2009年11月). 2018年3月10日閲覧。

nii.ac.jp

ci.nii.ac.jp

岡野高明、高梨靖子、宮下伯容他「成人におけるADHD，高機能広汎性発達障害など発達障害のパーソナリティ形成への影響 - 成人パーソナリティ障害との関連 -」『精神科治療学』第19巻第4号、2004年4月、433-442頁、NAID 50000462975。
田中哲「ADHDの診断・治療指針に関する研究会，齊藤万比古（編）『注意欠如・多動症─ADHD─の診断・治療ガイドライン第4版』」『児童青年精神医学とその近接領域』第58巻第1号、2017年、200-201頁、doi:10.20615/jscap.58.1_200、NAID 130005708247。
『日本東洋医学雑誌』第62巻第3号、2011年、479-508頁、doi:10.3937/kampomed.62.479、NAID 40018899757。
「注意欠陥多動性障害(ADHD)に対する漢方処方の効果(小児科疾患,一般演題,伝統医学のあるべきかたちとは-世界の潮流と日本の役割-,第59回日本東洋医学会学術総会」『日本東洋醫學雜誌』59(別冊)第201号、2008年5月、NAID 110006839461。

id.nii.ac.jp

高橋恵美子、山下一也、阿川啓子、小村智子、「ADHDをもつ子供のためのSummer Treatment Programの意義 : いずもサマースクール実施に向けて」『島根県立大学短期大学部出雲キャンパス研究紀要』 2010年 4巻 p.137-143, 島根県立大学

kaken.nii.ac.jp

富田, 拓 (2023-12). 再犯予防のための刑務所受刑者に対する注意欠如多動症のスクリーニングと加療の試み.

nikkei.co.jp

release.nikkei.co.jp

東大、注意欠如多動性障害の薬物治療効果を予測する客観的な指標を開発

nikkei.com

woman.nikkei.com

“小島慶子　40過ぎてADHDと診断され自分知った”. 小島慶子のDUALな本音. 日経BP (2018年7月2日). 2023年3月11日閲覧。
“眞鍋かをり大人になり ADHD傾向目立たなくなった”. 日経WOMAN. (2018年11月27日) 2021年12月4日閲覧。

nise.go.jp

“第1部 ADHD に関連する各種の評価法”. 独立行政法人国立特殊教育総合研究所 (2004年). 2024年9月19日閲覧。

npo-jisedai.org

AD/HD - NPO日本次世代育成支援協会

nytimes.com

“The Selling of Attention Deficit Disorder”. NYTimes. (2013年12月14日)

ohchr.org

www2.ohchr.org

国連子どもの権利員会 [英語版] (20 June 2010). Consideration of reports submitted by States parties under article 44 of the Convention - Concluding observations: Japan CRC/C/JPN/CO/3 (pdf) (Report). The United Nations Convention on the Rights of the Child (UNCRC). 2013年6月7日閲覧. 邦訳：国連子どもの権利員会：総括所見：日本第3回

oricon.co.jp

“パリス・ヒルトン、約20年ぶりニューアルバムで“自省的な旅””. ORICON NEWS (2024年9月6日). 2024年9月8日閲覧。

pacificcollege.edu

Treating ADHD with Acupuncture | Pacific College

pmda.go.jp

塩野義製薬株式会社, [https://www.pmda.go.jp/drugs/2019/P20190315001/340018000_23100AMX00296_G100_1.pdf ビバンセカプセル20mg, 同30mg 第2部（モジュール2）:CTDの概要（サマリー） 2.5 臨床に関する総括評価]

info.pmda.go.jp

ヤンセン・ファーマ「コンサータ錠添付文書」 (1 ed.), 医薬品医療機器総合機構, (2007年12月作成エラー: 日付が正しく記入されていません。) 2009年6月1日閲覧。

psych.or.jp

自閉スペクトラム症を持つ方々の他者理解

psychiatryonline.org

gun-violence.psychiatryonline.org

Lynne Lamberg (2014-09). “Children With ADHD Benefit From Sleep-Focused Treatment”. Gun Violence and Mental Health 49 (8): 1.

psychologytoday.com

アレン・フランセス (2016年5月23日). “ADHD Is Overdiagnosed, Here's Proof”. Psycology Today. 2018年3月10日閲覧。
Marilyn Wedge (2012年5月8日). “Why French Kids Don't Have ADHD”. Psycology Today. 2018年3月10日閲覧。